Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer

Journal of Surgical Oncology

Volumn 103, Issue 3, 2011, Pages 223-229

  Kobayashi, Shogo ^a   Nagano, Hiroaki ^a   Hoshino, Hiromitsu ^a   Wada, Hiroshi ^a   Marubashi, Shigeru ^a   Eguchi, Hidetoshi ^a   Takeda, Yutaka ^a   Tanemura, Masahiro ^a   Kim, Tonsok ^b   Shimosegawa, Eku ^b   Hatazawa, Jun ^b   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Biliary cancer; FDG PET; Surgical outcome

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BILIARY TRACT SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BILIARY TRACT NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 79952022819     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21811     Document Type: Article

References (29)

1. Japanese Society of Biliary Surgery. Classification of biliary tract carcinoma, 5th edition. Tokyo: Kanehara; 2003.
2. Miyakawa S, Ishihara S, Horiguchi A, et al.: Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998-2004 in Japan. J Hepatobiliary Pancreat Surg 2009;16:1-7.
3. Hong SM, Cho H, Lee OJ, et al.: The number of metastatic lymph nodes in extrahepatic bile duct carcinoma as a prognostic factor. Am J Surg Pathol 2005;29:1177-1183. (Pubitemid 41232990)
4. Sakata E, Shirai Y, Yokoyama N, et al.: Clinical significance of lymph node micrometastasis in ampullary carcinoma. World J Surg 2006;30:985-991. (Pubitemid 43824408)
5. DeOliveira ML, Cunningham SC, Cameron JL, et al.: Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007;245:755-762. (Pubitemid 46684105)
6. Otani K, Chijiiwa K, Kai M, et al.: Outcome of surgical treatment of hilar cholangiocarcinoma. J Gastrointest Surg 2008;12:1033-1040.
7. Woo SM, Ryu JK, Lee SH, et al.: Recurrence and prognostic factors of ampullary carcinoma after radical resection: Comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol 2007;14:3195-3201. (Pubitemid 47594288)
8. Falconi M, Crippa S, Domínguez I, et al.: Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. Ann Surg Oncol 2008;15:3178-3186.
9. van der Gaag NA, ten Kate FJ, Lagarde SM, et al.: Prognostic significance of extracapsular lymph node involvement in patients with adenocarcinoma of the ampulla of Vater. Br J Surg 2008;95:735-743.
10. Choi SB, Park SW, Kim KS, et al.: The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection. J Surg Oncol 2009;99:335-342.
11. Kobayashi S, Nagano H, Marubashi S, et al.: Impact of postoperative irradiation after non-curative resection of hilar biliary cancer. J Surg Oncol 2009;100:657-662.
12. Kobayashi S, Nagano H, Marubashi S, et al.: Multi-detector computed tomography for preoperative prediction of postsurgical prognosis of patients with extrahepatic biliary cancer. J Surg Oncol 2010;101:376-383.
13. Noji T, Kondo S, Hirano S, et al.: Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer. Br J Surg 2008;95:92-96. (Pubitemid 351184920)
14. Li J, Kuehl H, Grabellus F, et al.: Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol 2008;98:438-443.
15. Furukawa H, Ikuma H, Asakura-Yokoe K, et al.: Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: Prospective comparison with PET + CT, MDCT and histopathology. Eur Radiol 2008;18:2841-2847.
16. Kim JY, Kim MH, Lee TY, et al.: Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: A prospective study compared with conventional imaging. Am J Gastroenterol 2008;103:1145-1151. (Pubitemid 351677961)
17. Petrowsky H, Wildbrett P, Husarik DB, et al.: Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 2006;45:43-50. (Pubitemid 43850623)
18. Anderson CD, Rice MH, Pinson CW, et al.: Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004;8:90-97. (Pubitemid 38117282)
19. Moon CM, Bang S, Chung JB, et al.: Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. J Gastroenterol Hepatol 2008;23:759-765. (Pubitemid 351519420)
20. Nishiyama Y, Yamamoto Y, Kimura N, et al.: Comparison of early and delayed FDG PET for evaluation of biliary stricture. Nucl Med Commun 2007;28:914-919. (Pubitemid 350306783)
21. Furukawa H, Ikuma H, Asakura K, et al.: Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma. J Surg Oncol 2009;100:494-499.
22. Sobin LH, Wittekind C, International Union Against Cancer: TNM classification of malignant tumors, 6th edition. New York: Wiley-Liss; 2002.
23. Noji T, Kondo S, Hirano S, et al.: CT evaluation of paraaortic lymph node metastasis in patients with biliary cancer. J Gastroenterol 2005;40:739-743. (Pubitemid 41349086)
24. Showalter TN, Miller TR, Huettner P, et al.: 18F-fluorodeoxyglucose- positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer. Int J Gynecol Cancer 2009;19:1412-1414.
25. Nakamura K, Kodama J, Okumura Y, et al.: The of 18F-FDG PET correlates with histological grade in endometrial cancer. Int J Gynecol Cancer 2010;20:110-115.
26. Murakami S, Saito H, Sakuma Y, et al.: Correlation of (18)F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size. Eur J Radiol 2010;75:e126-e132.
27. Kim YC, Park MS, Cha SW, et al.: Comparison of CT and MRI for presurgical characterization of paraaortic lymph nodes in patients with pancreatico-biliary carcinoma. World J Gastroenterol 2008;14:2208-2212.
28. Maithel SK, Khalili K, Dixon E, et al.: Impact of regional lymph node evaluation in staging patients with periampullary tumors. Ann Surg Oncol 2007;14:202-210. (Pubitemid 44954290)
29. Valle JW, Wasan H, Johnson P, et al.: Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: A multicentre randomised phase II study - The UK ABC-01. Study Br J Cancer 2009;101:621-627.